Dailypharm Live Search Close

Samsung BioLogics' sales surpassed ₩1 trillion

By Chon, Seung-Hyun | translator Choi HeeYoung

21.10.26 16:09:54

°¡³ª´Ù¶ó 0
3Q cumulative sales of ₩11,648 trillion, ¡è42% year-on-year

Consignment production by global pharmaceutical companies has increased

 ¡ãView of Samsung BioLogics Plant 3

Samsung BioLogics surpassed 1 trillion won in sales in three quarters. Sales exceeded 1 trillion won in nine years after its establishment last year, and it showed a steeper rise this year.

Samsung Biologics announced on the 26th that its operating profit as of the third quarter was 167.4 billion won, up 196.12% from a year earlier. Sales amounted to 408.5 billion won, up 104.02% from the previous year. Both sales and operating profit are the largest ever. It broke new records of sales (412.2 billion won) and operating profit (166.8 billion won) set in the second quarter again in one quarter.

Samsung Biologics' cumulative sales in the third quarter amounted to 1.1237 trillion won, up 42.3

Chon, Seung-Hyun(1000@dailypharm.com)
If you want to see the full article, please JOIN US (click)